Table 3.
Responses |
All patients (n = 104) [n or %] |
BBM (n = 40) [n or %] |
Non-BBM (n = 64) [n or %] |
---|---|---|---|
CR | 0 (0.0) | 0 | 0 |
PR | 86 (82.7) | 34 (85.0) | 52 (81.3) |
SD | 16 (15.4) | 6 (15.0) | 10 (15.6) |
PD | 2 (1.9) | 0 | 2 (3.1) |
ORR | 82.7% [95% CI, 75–90%] |
85.0%* | 81.3% |
DCR | 98.1% [95% CI, 95–101%] |
100%** | 96.9% |
P = 0.791 vs. Non-BBM.
P = 0.522 vs. Non-BBM.
CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD stable disease; BBM, baseline brain-metastases; Non-BMM, without baseline brain-metastases.